BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20526555)

  • 1. Psoriasiform drug eruption induced by anti-tuberculosis medication: potential role of plasma-cytoid dendritic cells.
    Park JJ; Choi YD; Lee JB; Kim SJ; Lee SC; Won YH; Yun SJ
    Acta Derm Venereol; 2010 May; 90(3):305-6. PubMed ID: 20526555
    [No Abstract]   [Full Text] [Related]  

  • 2. Lichenoid eruption associated with antituberculous drug; an unusual oral and follicular involvement.
    Byun JW; Bang CY; Choi GS; Shin J
    Am J Dermatopathol; 2014 Aug; 36(8):684-5. PubMed ID: 23823026
    [No Abstract]   [Full Text] [Related]  

  • 3. Psoriasiform drug eruption due to abatacept.
    Kato K; Satoh T; Nishizawa A; Yokozeki H
    Acta Derm Venereol; 2011 May; 91(3):362-3. PubMed ID: 21336469
    [No Abstract]   [Full Text] [Related]  

  • 4. Generalized fixed drug eruption caused by pazufloxacin.
    Sawada Y; Nakamura M; Tokura Y
    Acta Derm Venereol; 2011 Sep; 91(5):600-1. PubMed ID: 21597677
    [No Abstract]   [Full Text] [Related]  

  • 5. Mixed lichenoid and psoriasiform drug eruption induced by rifampicin.
    Feng X; Ye X; Xu J; Li C
    Australas J Dermatol; 2020 May; 61(2):e231-e233. PubMed ID: 31840241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythema gyratum repens-like eruption occuring in resolving psoriasis during methotrexate therapy.
    Singal A; Sonthalia S; Pandhi D
    Int J Dermatol; 2010 Mar; 49(3):306-7. PubMed ID: 20465670
    [No Abstract]   [Full Text] [Related]  

  • 7. A Case of Ixekizumab-induced Psoriasiform Eruption.
    Oiwa T; Fujita M; Takase S; Nishimura Y; Ota M; Okada K; Tachibana T
    Acta Derm Venereol; 2019 Apr; 99(4):446-447. PubMed ID: 30723870
    [No Abstract]   [Full Text] [Related]  

  • 8. Transition of psoriasiform drug eruption to psoriasis de novo evidenced by histopathology.
    Yamamoto M; Ikeda M; Kodama H; Sano S
    J Dermatol; 2008 Nov; 35(11):732-6. PubMed ID: 19120769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasiform and pustular eruption induced by infliximab.
    Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Ashida T; Kohgo Y; Iizuka H
    J Dermatol; 2007 Jul; 34(7):468-72. PubMed ID: 17584325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasiform eruption induced by alpha1-adrenergic blocker, urapidil.
    Takehara Y; Igawa K; Satoh T; Yokozeki H
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):577-8. PubMed ID: 17374017
    [No Abstract]   [Full Text] [Related]  

  • 11. Psoriatic Erythroderma Caused by Terbinafine: A Possible Pathogenetic Role for IL-23.
    Oda T; Sawada Y; Yamaguchi T; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Okada E; Nakamura M
    J Investig Allergol Clin Immunol; 2017; 27(1):63-64. PubMed ID: 28211348
    [No Abstract]   [Full Text] [Related]  

  • 12. Methotrexate-induced papular eruption following treatment of psoriasis.
    Mebazaa A; Kenani N; Denguezli M; Ben Salem C; Ziadi S; Sriha B; Belajouza C; Nouira R
    Ann Pharmacother; 2008 Jan; 42(1):138-41. PubMed ID: 18094347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valsartan-induced drug eruption followed by CD30+ pseudolymphomatous eruption.
    Sawada Y; Yoshiki R; Kawakami C; Fukamachi S; Sugita K; Nakamura M; Tokura Y
    Acta Derm Venereol; 2010 Sep; 90(5):521-2. PubMed ID: 20814632
    [No Abstract]   [Full Text] [Related]  

  • 14. Psoriasiform dermatitis in a non-psoriatic patient treated with adalimumab.
    Tammaro A; Persechino S; Abruzzese C; Narcisi A; Cortesi G; Parisella FR; Laganà B
    Int J Immunopathol Pharmacol; 2012; 25(2):499-501. PubMed ID: 22697082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent erythema annulare centrifugum during ustekinumab treatment in a psoriatic patient.
    Chou WT; Tsai TF
    Acta Derm Venereol; 2013 Mar; 93(2):208-9. PubMed ID: 22983014
    [No Abstract]   [Full Text] [Related]  

  • 16. [Baboon syndrome].
    Oehler E; Eftekari-Hassanlouie S; Le Guern A
    Rev Prat; 2014 Dec; 64(10):1348. PubMed ID: 25665308
    [No Abstract]   [Full Text] [Related]  

  • 17. Psoriasiform eruptions during anti TNF-alpha treatment: psoriasis or not?
    Seneschal J; Lepreux S; Milpied B; Schaeverbeke T; Taïeb A
    Arch Dermatol; 2007 Dec; 143(12):1593-5; author reply 1595. PubMed ID: 18087021
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-pigmenting fixed drug eruption induced by sorafenib.
    Tanabe K; Amoh Y; Mii S; Eto H; Iwamura M; Katsuoka K
    Acta Derm Venereol; 2010 May; 90(3):307. PubMed ID: 20526556
    [No Abstract]   [Full Text] [Related]  

  • 19. Fixed drug eruption (phenolphthalein). Evidence for a blood-borne mediator.
    Wyatt E; Greaves M; Sondergaard J
    Arch Dermatol; 1972 Nov; 106(5):671-3. PubMed ID: 4117910
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxic erythema with generalized follicular pustules caused by streptomycin.
    Kushimoto H; Aoki T
    Arch Dermatol; 1981 Jul; 117(7):444-5. PubMed ID: 6455093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.